CN Stock MarketDetailed Quotes

Shanghai Universal Biotech (301166)

Watchlist
  • 27.20
  • +0.44+1.64%
Market Closed Jun 12 15:00 CST
2.34BMarket Cap-92.83P/E (TTM)

About Shanghai Universal Biotech Company

Since its establishment in 2004, the company has been dedicated to antibodies and related products, positioning itself as a leading, comprehensive domestic supplier and expert in the field. Over more than a decade, it has steadily evolved into a one-stop provider of life-science solutions. The company serves higher education institutions, research institutes, hospitals, and biopharmaceutical enterprises, offering antibody-centric life-science reagents, along with associated instruments, consumables, and integrated technical services. Its core product category is life-science reagents. Corporate honors include: 2022—Top 100 Brands in China's Life-Science Services Sector; BD Outstanding Distributor Award; CST Best Digital Marketing Award; Cytiva Partnership in Good Times and Bad Award; Bio-Techne Best Partner Award, among others.

Company Profile

Short Name-A优宁维
Symbol-A301166
Company NameShanghai Universal Biotech Co.,Ltd.
Listing DateDec 28, 2021
Issue Price86.06
Shares Offered21.67M share(s)
FoundedOct 22, 2004
Legal Representativezhaowu leng
General Managerzhaowu leng
Secretaryyanfang qi
Accounting FirmLixin Zhonglian Certified Public Accountants (Special General Partnership)
Securities Representativeqingli xia
Legal CounselJintiancheng Law Firm, Shanghai
Employees203
Phone021-38939097
Office AddressBuilding 16, Lane 15, Gudan Road, Pudong New Area, Shanghai
Zip Code201314
Registered AddressRoom 1505, No. 1690 Kongjiang Road, Yangpu District, Shanghai
Fax021-38015116
Emailir@univ-bio.com
Business License

310110000346444

Business

Permitted Activities: Operation of Class III medical devices; provision of Value-Added Telecommunications Services of Category II. (For items that, according to law, require approval, business activities may be carried out only upon approval by the relevant authorities; the specific scope of business shall be subject to the approval documents or licenses issued by the relevant authorities.) General Activities: Technical services, technological development, technical consulting, technology exchange, technology transfer, and technology promotion; natural science research and experimental development; sale of Class I medical devices; sale of Class II medical devices; sale of specialized chemical products (excluding hazardous chemicals); sale of laboratory analytical instruments; sale of instruments and meters; import and export of goods; import and export of technology; wholesale of computer software and hardware and related auxiliary equipment; retail of computer software and hardware and related auxiliary equipment; operation of hazardous chemicals. (Except for items that, according to law, require approval, business activities may be conducted independently in accordance with the business license.)

Company Executives

  • Name
  • Position
  • Salary
  • zhaowu leng
  • Chairman, Director, General Manager, Member of the Nomination Committee, Chairperson of the Strategic Committee, Member of the Compensation and Assessment Committee
  • 1.78M
  • zhaowen leng
  • Director, Member of the Audit Committee
  • --
  • yin zhou
  • Director, Deputy General Manager
  • 1.25M
  • min tang
  • Director, Deputy General Manager, Chief Financial Officer
  • 1.40M
  • xiaoping xu
  • Director, Deputy General Manager
  • 1.06M
  • yun chen
  • Director
  • --
  • qian xu
  • Independent Director, Member of the Audit Committee, Chairperson of the Compensation and Assessment Committee, Member of the Strategic Committee, Member of the Nomination Committee
  • --
  • weidong lai
  • Independent Director, Member of the Strategic Committee, Chairperson of the Nomination Committee
  • --
  • yuchao jin
  • Independent Director, Chairperson of the Audit Committee, Member of the Compensation and Assessment Committee
  • 80.00K
  • yanfang qi
  • Board Secretary, Deputy General Manager
  • 971.80K
  • qingli xia
  • Securities Affairs Representative
  • --
  • hongyang pan
  • Deputy General Manager
  • 1.40M
  • wei mou
  • Deputy General Manager
  • 924.60K
  • bing hu
  • Deputy General Manager
  • 992.60K
  • waying chen
  • Deputy General Manager
  • 1.10M
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More